| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0928-0197(98)00038-5 |
| P698 | PubMed publication ID | 9741645 |
| P2093 | author name string | Stephenson J | |
| P2860 | cites work | Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a | Q27486615 |
| Epidemiology of hepatitis C | Q28249543 | ||
| Functional diversity of helper T lymphocytes | Q29619415 | ||
| Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector | Q35068584 | ||
| Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy | Q35232341 | ||
| Flavivirus vaccines | Q39329415 | ||
| Studies of Japanese Encephalitis in China | Q40132209 | ||
| Gene therapy and viral vaccination: the interface | Q40537224 | ||
| Stabilized 17D strain yellow fever vaccine: dose response studies, clinical reactions and effects on hepatic function | Q40884871 | ||
| Yellow fever vaccine. IV. Reactogenicity and antibody response in volunteers inoculated with a vaccine free from contaminating avian leukosis viruses | Q40920232 | ||
| Oral or parenteral administration of replication-deficient adenoviruses expressing the measles virus haemagglutinin and fusion proteins: protective immune responses in rodents | Q41039795 | ||
| High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model | Q41326234 | ||
| Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view | Q41574262 | ||
| Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein | Q42987710 | ||
| The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants | Q43035846 | ||
| The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell | Q43036438 | ||
| Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1. | Q43049588 | ||
| Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine | Q64378203 | ||
| Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation | Q70148771 | ||
| P433 | issue | 2-3 | |
| P921 | main subject | Flaviviridae | Q1331256 |
| Adenoviridae | Q193447 | ||
| P304 | page(s) | 187-194 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | Clinical and diagnostic virology | Q27714224 |
| P1476 | title | Defective adenoviruses as novel vaccines for the Flaviviridae | |
| P478 | volume | 10 |
| Q37812291 | A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies |
| Q40207805 | Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis |
| Q58535137 | CD8+ T-Cell Tolerance can be Broken by an Adenoviral Vaccine While CD4+ T-Cell Tolerance is Broken by Additional Co-administration of a Toll-Like Receptor Ligand |
| Q40510477 | Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein |
| Q45874123 | Innovations in oral gene delivery: challenges and potentials. |
| Q36690209 | Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors |
| Q35728621 | Recent advancement in flavivirus vaccine development |
| Q43970020 | Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection |
| Q27487570 | Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2 |
| Q54707168 | Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs. |
| Q35143285 | Traditional and novel approaches to flavivirus vaccines |
Search more.